Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Role and mechanism of tissue plasminogen activator in venous wall fibrosis remodeling after deep venous thrombosis via the glycogen synthase kinase-3 beta signaling pathway.

Yin M, Tian S, Huang X, Huang Y, Jiang M.

J Surg Res. 2013 Oct;184(2):1182-95. doi: 10.1016/j.jss.2013.03.100. Epub 2013 Apr 18.

PMID:
23632004
2.
3.

Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model.

Deatrick KB, Eliason JL, Lynch EM, Moore AJ, Dewyer NA, Varma MR, Pearce CG, Upchurch GR, Wakefield TW, Henke PK.

J Vasc Surg. 2005 Jul;42(1):140-8.

4.

tPA activates LDL receptor-related protein 1-mediated mitogenic signaling involving the p90RSK and GSK3beta pathway.

Lin L, Bu G, Mars WM, Reeves WB, Tanaka S, Hu K.

Am J Pathol. 2010 Oct;177(4):1687-96. doi: 10.2353/ajpath.2010.100213. Epub 2010 Aug 19.

5.

C-Peptide induces vascular smooth muscle cell proliferation: involvement of SRC-kinase, phosphatidylinositol 3-kinase, and extracellular signal-regulated kinase 1/2.

Walcher D, Babiak C, Poletek P, Rosenkranz S, Bach H, Betz S, Durst R, Grüb M, Hombach V, Strong J, Marx N.

Circ Res. 2006 Nov 24;99(11):1181-7. Epub 2006 Oct 26.

7.

P-selectin inhibition enhances thrombus resolution and decreases vein wall fibrosis in a rat model.

Myers DD Jr, Henke PK, Wrobleski SK, Hawley AE, Farris DM, Chapman AM, Knipp BS, Thanaporn P, Schaub RG, Greenfield LJ, Wakefield TW.

J Vasc Surg. 2002 Nov;36(5):928-38.

8.

Inhibitory effects of cilostazol on proliferation of vascular smooth muscle cells (VSMCs) through suppression of the ERK1/2 pathway.

Yoo AR, Koh SH, Cho GW, Kim SH.

J Atheroscler Thromb. 2010 Oct 27;17(10):1009-18. Epub 2010 Aug 14.

9.
10.

Fibrotic injury after experimental deep vein thrombosis is determined by the mechanism of thrombogenesis.

Henke PK, Varma MR, Moaveni DK, Dewyer NA, Moore AJ, Lynch EM, Longo C, Deatrick CB, Kunkel SL, Upchurch GR Jr, Wakefield TW.

Thromb Haemost. 2007 Nov;98(5):1045-55.

PMID:
18000610
11.

The role of urokinase plasminogen activator and plasmin activator inhibitor-1 on vein wall remodeling in experimental deep vein thrombosis.

Baldwin JF, Sood V, Elfline MA, Luke CE, Dewyer NA, Diaz JA, Myers DD, Wakefield T, Henke PK.

J Vasc Surg. 2012 Oct;56(4):1089-97. doi: 10.1016/j.jvs.2012.02.054. Epub 2012 Jul 15.

12.

Upregulation of TRPM7 channels by angiotensin II triggers phenotypic switching of vascular smooth muscle cells of ascending aorta.

Zhang Z, Wang M, Fan XH, Chen JH, Guan YY, Tang YB.

Circ Res. 2012 Oct 12;111(9):1137-46. doi: 10.1161/CIRCRESAHA.112.273755. Epub 2012 Aug 14. Erratum in: Circ Res. 2012 Dec 7;111(12):e391-2.

13.

Tissue plasminogen activator induces microglial inflammation via a noncatalytic molecular mechanism involving activation of mitogen-activated protein kinases and Akt signaling pathways and AnnexinA2 and Galectin-1 receptors.

Pineda D, Ampurdanés C, Medina MG, Serratosa J, Tusell JM, Saura J, Planas AM, Navarro P.

Glia. 2012 Apr;60(4):526-40. doi: 10.1002/glia.22284. Epub 2011 Dec 7.

PMID:
22162045
14.

Co-operation between the AKT and ERK signaling pathways may support growth of deep endometriosis in a fibrotic microenvironment in vitro.

Matsuzaki S, Darcha C.

Hum Reprod. 2015 Jul;30(7):1606-16. doi: 10.1093/humrep/dev108. Epub 2015 May 14.

PMID:
25976656
15.

Plasminogen activator inhibitor-1 promotes the proliferation and inhibits the apoptosis of pulmonary fibroblasts by Ca(2+) signaling.

Zhang YP, Wang WL, Liu J, Li WB, Bai LL, Yuan YD, Song SX.

Thromb Res. 2013 Jan;131(1):64-71. doi: 10.1016/j.thromres.2012.09.003. Epub 2012 Sep 25.

PMID:
23021499
16.

Vein wall re-endothelialization after deep vein thrombosis is improved with low-molecular-weight heparin.

Moaveni DK, Lynch EM, Luke C, Sood V, Upchurch GR, Wakefield TW, Henke PK.

J Vasc Surg. 2008 Mar;47(3):616-24. doi: 10.1016/j.jvs.2007.11.040.

17.

A role for the beta-catenin/T-cell factor signaling cascade in vascular remodeling.

Wang X, Xiao Y, Mou Y, Zhao Y, Blankesteijn WM, Hall JL.

Circ Res. 2002 Feb 22;90(3):340-7.

18.

Role of PI3K/AKT, cPLA2 and ERK1/2 signaling pathways in insulin regulation of vascular smooth muscle cells proliferation.

Isenović ER, Kedees MH, Tepavcević S, Milosavljević T, Korićanac G, Trpković A, Marche P.

Cardiovasc Hematol Disord Drug Targets. 2009 Sep;9(3):172-80. Review.

PMID:
19534657
19.

Urotensin II-induced collagen synthesis in cultured smooth muscle cells from rat aortic media and a possible involvement of transforming growth factor-β1/Smad2/3 signaling pathway.

Zhao J, Ding W, Song N, Dong X, Di B, Peng F, Tang C.

Regul Pept. 2013 Mar 10;182:53-8. doi: 10.1016/j.regpep.2012.12.006. Epub 2013 Feb 9.

PMID:
23403244
20.

Differential regulation of vascular smooth muscle and endothelial cell proliferation in vitro and in vivo by cAMP/PKA-activated p85alphaPI3K.

Torella D, Gasparri C, Ellison GM, Curcio A, Leone A, Vicinanza C, Galuppo V, Mendicino I, Sacco W, Aquila I, Surace FC, Luposella M, Stillo G, Agosti V, Cosentino C, Avvedimento EV, Indolfi C.

Am J Physiol Heart Circ Physiol. 2009 Dec;297(6):H2015-25. doi: 10.1152/ajpheart.00738.2009. Epub 2009 Sep 25.

Supplemental Content

Support Center